Rupatadine

Revision as of 15:48, 20 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
Jump to navigation Jump to search
Rupatadine
Clinical data
Routes of
administration		Oral
ATC code
Pharmacokinetic data
Protein binding99%
MetabolismHepatic, CYP-mediated
Elimination half-life5.9 hours
ExcretionFecal (60.9%) and renal (34.6%)
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC26H26ClN3
Molar mass415.958 g/mol

Overview

Rupatadine is a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. Ruptatadine is marketed by Panacea-Biotech under the trade name Ralif. Ralif is approved for the treatment of allergic rhinitis.

External links


Template:WH

Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Rupatadine&oldid=688162"